Trial intelligence / Profile preview

Intrathecal hyperbaric prilocaine versus low-dose hyperbaric bupivacaine for ambulatory lower limb orthopedic surgery

PACTR202609803765016Phase 4Completed

Sponsor
Ain Shams University Faculty of Medicine
Start
Oct 2022
Modality
Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in None comparing Intrathecal hyperbaric prilocaine plus fentanyl with Intrathecal low-dose hyperbaric bupivacaine plus fentanyl (2 arms). Primary endpoint: Time to first unassisted ambulation. Started Oct 2022; status: completed.

02

Drugs

prilocainebupivacainefentanyl

Beyond the preview

Go deeper on PACTR202609803765016.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR202609803765016.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call